Idexx Laboratories | IDXX - Current Liabilities

Stock Price
635.66
Daily Change
4.93 0.78%
Monthly
-8.73%
Yearly
40.39%
Q1 Forecast
615.95

Idexx Laboratories reported $1.15B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Accuray USD 194.61M 2.03M Sep/2025
Align Technology USD 1.92B 46.45M Dec/2025
AngioDynamics USD 77.97M 10.62M Feb/2025
Dentsply International USD 1.4B 239M Sep/2025
Dexcom USD 2.14B 1.19B Dec/2025
Edwards Lifesciences USD 1.59B 183.3M Sep/2025
Fujifilm JPY 1.2T 44.21B Dec/2025
Globus Medical USD 465.96M 41.29M Sep/2025
Henry Schein USD 3.15B 142M Sep/2025
Hologic USD 951.3M 25.9M Dec/2025
Idexx Laboratories USD 1.15B 103M Dec/2025
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 680.1M 32.4M Dec/2025
Integra LifeSciences USD 364.05M 565.75M Sep/2025
Intuitive Surgical USD 2.52B 207.3M Dec/2025
Masimo USD 369.7M 222.4M Sep/2025
Neogen USD 147.05M 850K Sep/2025
Orthofix International USD 159.85M 11.47M Sep/2025
Phibro Animal Health USD 282.37M 12.23M Dec/2025
ResMed USD 1.25B 7.39M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Steris USD 922.3M 33.4M Dec/2025
Tandem Diabetes Care USD 242.72M 9.82M Dec/2025
Teleflex USD 773.03M 56.88M Sep/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Zoetis USD 2.24B 428M Dec/2025